Dark

ABUS
Arbutus Biopharma Corporation Common Stock
stock NASDAQ

At Close

Jul 28, 2025 3:59:30 PM EDT

3.35USD+3.882%(+0.13)764,076

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jul 24, 2025 8:42:30 AM EDT

3.22USD0.000%(0.00)0

After-hours

Jul 25, 2025 4:00:30 PM EDT

3.22USD+0.156%(+0.01)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

639.70M

CEO

Mark Murray

Headquarters

Calgary, Alberta, Canada

Industry

Biotechnology

Next Earnings

Jul 31, 2025 (2d)

Last Split

Nov 4, 20101for5reverse

PDLI INFI CNAT XLV

ABUS Stats

Avg. Vol. 10 Day

636,865

Avg. Vol. 30 Day

821,844

Employees

130

Market Cap

639,700,611

Shares Out.

191,527,129

On/Off Exchange

61%/39%

6 Month Beta

0.85

1 Year Beta

0.78

2 Year Beta

0.81

3 Year Beta

0.83

52 Week Low

2.71

52 Week High

4.73

SMA50

3.29

SMA200

3.42

1 Week

+6.37%

1 Month

+6.71%

6 Month

-0.30%

1 Year

-11.64%

2 Year

+53.92%

5 Year

-16.92%

Profile

arbutus biopharma corporation (nasdaq:abus) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis b infection, a disease of the liver caused by hepatitis b virus (hbv). we are developing a portfolio of drug candidates with multiple mechanisms of action that we believe will result in a combination therapy that will transform the hbv treatment landscape and cure hepatitis b virus disease. in addition to our hbv assets, we are developing a pipeline of programs that leverage our expertise in rna interference (rnai) therapeutics and our lipid nanoparticle (lnp) technology.

ABUS Stock Summary

Arbutus Biopharma Corporation Common Stock (NASDAQ:ABUS) stock price today is $3.35, and today's volume is 764,076. ABUS is up 3.882% today. The 30 day average volume is 821,844. ABUS market cap is 639.70M with 191,527,129 shares outstanding.